Thank you, Ted. As I typically do, I'll cover the following topics during my portion of the call. I'll cover an overview of our 2024 third quarter results, along with an overview of related key operating statistics. I'll cover an overview of our cash flow activities in the quarter, and I will then conclude with a discussion on our financial outlook for the fourth quarter of 2024. For purposes of this call, I will comment separately regarding the revenues of our global S&BT segment, our Oracle solution segment, our SAP solution segment, and the total company. Our global S&BT segment includes the results of our North America and international GenAI consulting implementation, benchmarking and business transformation offerings, executive advisory and IPaaS programs, and our OneStream and e-procurement implementation offerings. Our Oracle solutions and our SAP solution segments include the results of our Oracle and SAP offerings respectively. Please note that we will be referencing both total revenue and revenue before reimbursements in our discussion. Reimbursable expenses are primarily project, travel related expenses, passed due to our clients, and have no associated impact on our profitability. During our call today, we will also reference certain non-GAAP financial measures. Which we believe provide useful information to investors. We've included reconciliations of GAAP to non-GAAP financial measures in our press release filed earlier today, and we'll post any additional information based on the discussion from this call in the investor relations page of the company's website. For the third quarter of 2024, our total revenues were $79.8 million. Our revenues before reimbursements were $77.9 million, which was above the high end of our quarterly guidance. The third quarter of 2024 reimbursable expense ratio on revenue before reimbursements was 2.3%, as compared to 1.6% in the prior quarter, and in the same period in the prior year. Total revenues from our global S&BT segment were $44.1 million for the third quarter of 2024. Revenues before reimbursements for our global S&BT segment were $43.3 million for the third quarter of 2024, essentially flat when compared to the same period in the prior year. As Tim mentioned, the revenue from our GenAI consulting and implementation projects in this segment were primarily offset by weakness in our e-procurement implementation offerings. Total revenues from our Oracle Solutions segment were $22.8 million for the third quarter of 2024. Revenues before reimbursements for our Oracle Solutions segment were $21.8 million for the third quarter of 2024, an increase of 7% when compared to the same period in the prior year. These results continue the strong momentum we've experienced since the second quarter of 2023. Total revenues from our SAP Solutions segment were $13 million for the third quarter of 2024. Revenues before reimbursements for our SAP Solutions segment were $12.9 million for the third quarter, an increase of 17% when compared to the same period in the prior year, primarily driven by strong software-related sales in the quarter. Approximately 22% of our total company revenues before reimbursements consisted of recurring, multi-year, and subscription-based revenues, which includes our research advisory, IP as a service, multi-year benchmarks, and application-managed services contracts. Total company adjusted cost of sales, which exclude reimbursable expenses, non-cash stock-based compensation expense, and all acquisition-related cash and non-cash compensation expense totaled $44.2 million, or 56.8% of revenues before reimbursements in the third quarter, as compared to $42.9 million, or 57.5% of revenues before reimbursements in the prior year. Total company consultant headcount was 1,262, at the end of the third quarter of 2024, as compared to 1,105 in the previous quarter and 1,177 at the end of the third quarter of the prior year. Third quarter ending headcount was primarily driven by increases from our GenAI acquisition practice. Total company adjusted gross margin on revenues before reimbursements, which excludes reimbursable expenses and non-cash stock-based compensation expense, and all acquisition-related cash and non-cash compensation was 43.2% in the third quarter, as compared to 42.5% in the prior year, driven due to the revenue growth from both our Oracle and SAP segments. Adjusted SG&A, which excludes non-cash stock-based compensation expense and all acquisition-related cash and non-cash expenses was $17 million, or 21.8% of revenues before reimbursements in the third quarter. This is compared to $15.3 million, or 20.5% of revenues before reimbursements in the prior year. The year-over-year absolute dollar increase is primarily due to foreign exchange fluctuations, as well as incremental commissions from increased SAP and Oracle segment sales. Adjusted EBITDA, which excludes non-cash stock-based compensation expense and all acquisition-related cash and non-cash expenses, was $17.7 million, or 22.7% of revenues before reimbursements in the third quarter, as compared to $17.3 million, or 23.2% of revenues before reimbursements in the prior year. GAAP net income from the third quarter of 2024 totaled $8.6 million or diluted earnings per share of $0.31, as compared to gap net income of $9.4 million, or diluted earnings per share of $0.34 in the third quarter of the prior year. GAAP net income for the third quarter includes non-cash stock compensation expense from our recently approved Share Price Appreciation Equity Program of $602,000, and acquisition-related non-cash compensation expense of $232,000, which in total impacted our GAAP results by $0.02. Adjusted net income, which excludes non-cash stock-based compensation expense and all acquisition-related cash and non-cash expenses, for the third quarter of 2024 totaled $12.1 million, or adjusted diluted net income per common share of $0.43, which is above the top-end of our earnings guide range and compares to our prior year adjusted diluted net income per common share of $0.41. Our adjusted net income for the third quarter of 2024 was favorably impacted by approximately $0.01 due to a lower GAAP effective tax rate on adjusted earnings than we originally estimated when we provided guidance last quarter. As announced in September 2024, during the third quarter, the company acquired the operations of LeewayHertz, an India-based AI implementation services firm. Due to the timeliness of transaction, this acquisition did not have an impact on our adjusted net income for the third quarter of 2024. Acquisition-related cash and non-cash stock compensation expense relates to a portion of the purchase consideration for the LeewayHertz acquisition. This consideration contains either performance or service vesting requirements and as such is reflected as compensation expense under GAAP rather than purchase consideration. The company's cash balances were $10 million at the end of the third quarter of 2024 as compared to $19.1 million at the end of the previous quarter. Net cash provided from operating activities in the quarter was $10.6 million primarily driven by net income adjusted for non-cash activity partially offset by increases in accounts receivable. Our DSO or day sales outstanding was 70 days at the end of the quarter as compared to 68 days at the end of the previous quarter and as compared to 75 days in the prior year. Cash utilized for purchase consideration for the LeewayHertz acquisition amounted to $7.6 million in the quarter. This does not include any stock purchase consideration or any contingent compensation that may be earned in the future. During the third quarter of 2024, the company paid down $7 million on its credit facility. The balance of the company's total debt outstanding at the end of the third quarter of 2024 was approximately $20 million. Subsequent to the end of the quarter, the company has paid down an additional $3 million. During the quarter, we repurchased 71,000 shares of the company's stock for an average of $26.66 per share at a total cost of approximately $1.9 million. Driven by open market purchases and from employees to satisfy income tax withholding triggered by the vesting of restricted shares. Our remaining stock repurchase authorization at the end of the quarter was $11.1 million. At its most recent meeting, subsequent to quarter end, the company's board of directors authorized a $20 million increase in the company's share purchase authorization. Additionally, the board declared the fourth quarterly dividend of $0.11 per share for the shareholders of a record of December 20, 2024 to be paid on January 3, 2025. Before I move to guidance for the fourth quarter of 2024, I'd like to remind everyone of the seasonality of our business. Specifically, the increased holiday and vacation time that is historically taken in the fourth quarter would decrease our available billing days by approximately 10% when compared to the third quarter. The company estimates total revenue before reimbursements for the fourth quarter of 2024 to be in the range of $73.5 to $75 million. We expect all second revenues before reimbursements to be up and the total company will be up 3% to 5% when compared to the prior year. We estimate adjusted diluted net income per common share in the fourth quarter of 2024 to be in the range of $0.41 to $0.43 which assumes a GAAP effective tax rate on adjusted earnings of 27.6%. We expect the adjusted gross margins percentage of revenues before reimbursements to be approximately 45% to 46%. We expect adjusted SG&A and interest expense for the fourth quarter to be approximately $17.2 million. We expect fourth quarter adjusted EBITDA as a percentage of revenues before reimbursements to be in the range of approximately 23% to 24%. Lastly, we expect cash flow from operations to be up on a sequential basis. At this point, I'll turn it back over to Ted to review our market outlook and strategic priorities for the coming months.